エピレプシの小児患者における薬剤の障壁

Sara E Molisani¹, Michael C Kaufman², Jaclyn Tencer¹

¹Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Departments of Neurology and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Pediatric neurology

|February 14, 2026

まとめ

小児性エピレプシーにおける薬剤耐用性の障壁を特定することは極めて重要です. スクリーニングは,副作用や投与量の記憶などの一般的な問題を明らかにし,介入の分野を強調しました.

科学分野:

小児神経学について
エピレプシーの管理
薬剤耐用性研究薬剤耐用性研究

背景:

小児性症は,効果的な発作制御のために一貫した薬剤の遵守を必要とします.
投薬の遵守に対する障壁を特定することは,を患っている子供の治療結果を最適化するために不可欠です.

研究の目的:

エピレプシーを患っている小児の患者で,薬の服用に最も頻繁な障壁を特定する.
これらの障壁に対する標準化されたスクリーニングの実現可能性を評価する.

主な方法:

エピレプシーのフォローアップ訪問のための予備調査アンケートとして,アデッセンスの障壁のツールの実装.
定義された期間における小児患者の大きなコホートからの応答の分析.

主要な成果:

フォローアップでの遭遇の74%以上がアンケートに記入し,35%が少なくとも1つの障害を報告した.
共通する障壁には,副作用 (25%),不有効な発作制御 (16%),薬の記憶障害 (12%) が含まれていた.
障壁は,黒人/アフリカ系アメリカ人の患者,頻繁に発作する患者,または複数の抗発作薬を服用している患者においてより一般的であった.

結論:

薬剤耐性障害に対する標準化されたスクリーニングは,小児神経学の環境で実行可能であり,持続可能であり,繰り返し可能です.
特定された共通の障壁は,小児性の遵守を改善するための将来の介入戦略のターゲットを提供します.

キーワード:

アデレンス・バリアは,アデレンス・バリアです.電子医療記録 (EHR) について薬の服用順守について小児性は小児性である.品質の向上品質の向上

さらに関連する動画

11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

2.5K

09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.0K

関連する概念動画

01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

281

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

281

01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

334

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

334

01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

256

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

256

01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

318

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

318

01:23

Inhaled Medications

843

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

843

01:24

Epilepsy and Seizures: Overview

1.4K

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...